A mysterious new opioid has emerged in the global opioid crisis, claiming hundreds of lives across the US and Europe. Nitazenes, a synthetic class of drugs 40 times more potent than fentanyl, have been steadily increasing on the streets, despite being largely unknown to authorities until recently.
Their origins date back to the 1950s when they were first synthesized by an Austrian chemical company. However, their use as painkillers never took off due to high addictiveness and respiratory depression risks. Nitazenes are now widely available in both the US and Europe, with dealers using them to cut other opioids, posing a significant threat to users who are unaware of what they're taking.
Their potency and similar effects to heroin make nitazenes an attractive substance for dealers, as it allows them to increase the volume of their operations. The lack of attention from authorities and an ill-defined legal status also makes it easier to trade. Nitazene use is now widespread throughout most of the US, with manufacturing taking place in Mexico or within the country in illegal laboratories supplied by Asian dealers.
In Europe, heroin has traditionally dominated the market, but a shortage of opium poppy cultivation due to the Taliban's ban on growing the crop could lead to an increase in synthetic opioids. Nitazenes have also been linked to recent deaths in Australia, underscoring the need for greater efforts to monitor and combat their spread.
Experts warn that nitazene use will likely continue to rise, mirroring the trend of fentanyl-related deaths. The lack of research on these substances and their unpredictable effects only add to the danger. As authorities struggle to keep up with the new threat, it's essential to acknowledge the severity of the situation and take action to prevent further fatalities.
Their origins date back to the 1950s when they were first synthesized by an Austrian chemical company. However, their use as painkillers never took off due to high addictiveness and respiratory depression risks. Nitazenes are now widely available in both the US and Europe, with dealers using them to cut other opioids, posing a significant threat to users who are unaware of what they're taking.
Their potency and similar effects to heroin make nitazenes an attractive substance for dealers, as it allows them to increase the volume of their operations. The lack of attention from authorities and an ill-defined legal status also makes it easier to trade. Nitazene use is now widespread throughout most of the US, with manufacturing taking place in Mexico or within the country in illegal laboratories supplied by Asian dealers.
In Europe, heroin has traditionally dominated the market, but a shortage of opium poppy cultivation due to the Taliban's ban on growing the crop could lead to an increase in synthetic opioids. Nitazenes have also been linked to recent deaths in Australia, underscoring the need for greater efforts to monitor and combat their spread.
Experts warn that nitazene use will likely continue to rise, mirroring the trend of fentanyl-related deaths. The lack of research on these substances and their unpredictable effects only add to the danger. As authorities struggle to keep up with the new threat, it's essential to acknowledge the severity of the situation and take action to prevent further fatalities.